Skip to main content

Table 2 Laboratory tests and clinical variables of study participants on follow up of ART at selected public and private health facilities of Adama town, East shewa zone, oromia, Ethiopia, 2021

From: Predictors of unsuppressed viral load among adults on follow up of antiretroviral therapy at selected public and private health facilities of Adama town: unmached case-control study

Variables

Case (n = 116)

Control (n = 231)

Frequency(percentage)

Frequency (percentage)

Base line hematology test done

 Yes

75 (64.7%)

153 (66.2%)

 No

41(33.3 5%)

78 (33.8%)

CD4 measurement done at base line

 Yes

87 (75%)

166 (71.9%)

 No

30 (25%)

65 (29. 1%)

CD4 result (N = 253)

  < 100 cell/micro liter

26 (22.4%)

18 (7.8%)

 100-200 cell/micro liter

25 (21.6%)

26 (11.3%)

 > 200 cell/micro liter

36 (31%)

122 (52.8%)

Adherence level

 Good

82 (70.7%)

221(95.7%)

 Fair

13 (11.2%)

2 (0.87%)

 Poor

21 (18.1%)

8 (3.5%)

Disclosure of sero-status

 Yes

81(69.8%)

136 (58.9%)

 No

35 (30. 2%)

95 (41.1%)

BMI

  

  < 18 kg/m2

26 (22.4%)

59 (25.5%)

 18.5-25 kg/m2

88 (75.9%)

153 (66.2%)

 > 25 kg/m2

2 (1.7%)

19(8.2%)

Baseline WHO clinical stage

 Stage I

62 (53.4%)

141 (61%)

 Stage II

15 (12.9%)

23 (10%)

 Stage III

33 (28.4%)

54 (23.4%)

 Stage IV

6 (25.6%)

13 (5.6%)

Baseline functional status

 Working

101 (87.2%)

208 (90%)

 Ambulatory

12 (10.3%)

20 (8.7%)

 Bedridden

3(2.5%)

3 (1.3%)

History of OI

 Yes

28 (24.1%)

42(18.2%)

 No

88 (73.9%)

189(81.8%)

History of chronic diarrhea

 Yes

18 (15.5%)

29 (12.6%)

 No

98 (84. 5%)

202 (85.4%)

History of chronic gastric problem

 Yes

8 (6.9%)

26 (11.3%)

 No

108 (93.1%)

205 (88.7%)